fbpx
WhatsApp: +1 (780) 996-0049
+1 (780) 996-0049

Category: News

"Natural Medicine Extractors"

Medxtractor announces a business refocus

Calgary, Alberta – July 27, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) announces a business refocus. Medxtractor (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) reports its plan to refocus to proprietary health-related databases, machine-learning analysis and associated applications. The planned changes are generally as follows: Continuing development of…
Read more

Medxtractor issues medical consultant share purchase options

Calgary, Alberta – July 16, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) issues medical consultant share purchase options. MedX (CSE: MXT, OTC:MXTTF) reports that it has granted a total of 300,000 medical consultant share purchase options, exercisable for 5 years at $0.18 per share, to three individuals. These…
Read more

Medxtractor reports filing of patent at USPTO

Calgary, Alberta – July 13, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) reports filing of a patent application at the United States Patent and Trademark Office (USPTO).  MedX (CSE: MXT, OTC:MXTTF) reports that it has been notified by it’s patent agent that U.S. Patent Application No. 63/220,004, METHOD OF…
Read more

Medxtractor reports share sales by majority shareholder

Calgary, Alberta – July 9, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) reports share sales by its majority shareholder. MedX (CSE: MXT, OTC:MXTTF) reports that it has been notified by it’s President and controlling shareholder James Durward, that he has sold, pursuant to a Form 45-102F1Notice of Intention…
Read more

UI-UX and progress update

Calgary, Alberta – June 30, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) update operations. MedX (CSE: MXT, OTC:MXTTF) reports that it is has now exceeded its Phase 2 target of 500 fully-completed reference records and the Phase 3 target of 800 reference records remains on track for the…
Read more

Medxtractor updates its reference record collection progress

Calgary, Alberta – June 15, 2021. For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) updates its reference record collection progress. MedX (CSE: MXT, OTC:MXTTF) reports that it is has now collected more than 400 complete reference records and is on track to reach its Phase 2 target of 500 fully-completed…
Read more

Medxtractor launches a mobile health initiative

For Immediate Release – Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) launches a mobile health (“mHealth”) initiative to apply machine-learning to predict personal health trajectories over time. MedX reports: Where SHAMAN is a business-to-business predictive product expecting to derive revenues from researchers, practitioners and application developers, the mHealth application is envisioned as an…
Read more

Medxtractor Corp. enters a Market Making Services Agreement

Calgary, Alberta – May 12, 2020. MXT reports that it has retained VLP to provide market-making services and will trade the securities of MXT on the CSE, on a best efforts-based basis, for the purposes of maintaining an orderly market and improving the liquidity in MXT’s shares. Beyond a monthly trading report, there are no…
Read more

MEDXTRACTOR CORP. REPORTS FINANCIAL RESULTS FOR YEAR ENDED FEBRUARY 28, 2021

Calgary, Alberta – May 11, 2021. MedXtractor Corp. (CSE: MXT) (“MedX” or the “Corporation”) updates its data record collection centre progress and its financial results for the year ended February 28, 2021. MedX reports that its data record collection centre has reached its practical capacity limit and the Corporation is now planning to expand to…
Read more

Provisional Patent Acquisition

Calgary, Alberta – April 13, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) announces acquisition of a provisional US patent related to SHAMAN’s foundational processes. Medxtractor Corp. (the “MXT”) reports that it has acquired all rights to United States Provisional Patent application number 63132186, “Novel Method of Generating Credible Solutions from Non-validated Datasets” (the “Application”).…
Read more